Subscribe

Original Research

Response-Guided Therapy an Appropriate Tool for Evaluating Treatment Protocols and Costs of Drug Therapies
Employers’ Obesity Initiatives in the Workplace: A Wakeup Call for Health Plans
Benefit Management Considerations for BPH Medications: Single Agent or Combination Therapy?
A Collaborative Approach to Drug Selection, Driven by Clinical Outcomes Excellence
When More Is Almost Always Better
Efficacy and Cost-Effectiveness: Escitalopram versus Citalopram
Health Plans Must “COPE” with Chronic Diseases
New Strategies Needed to Combat Increasing Costs and Optimize Use of Infused Therapies
Stakeholder Integration Crucial to Improved Patient Outcomes: Lessons from a Health Plan’s Experience
Value-Based Insurance Design: Evolving Strategies to Improve Medication Adherence, Control Healthcare Utilization
Page 8 of 8
Results 71 - 80 of 80
Copyright © Engage Healthcare Communications, LLC. All rights reserved.